Characterization of a novel <i>MEF2D-BCL9</i> fusion-positive acute lymphoblastic leukemia cell line

• Inge van Outersterp,
• Femke M. Hormann,
• Alex Q. Hoogkamer,
• Aurélie Boeree,
• Stijn A. van den Broek,
• Monique L. den Boer,
• Judith M. Boer

Affiliations

Inge van Outersterp

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands

Femke M. Hormann

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands; Erasmus MC - Sophia Children's Hospital, Department of Pediatric Oncology and Hematology, Rotterdam, Netherlands

Alex Q. Hoogkamer

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands

Aurélie Boeree

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands

Stijn A. van den Broek

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands

Monique L. den Boer

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands; Erasmus MC - Sophia Children's Hospital, Department of Pediatric Oncology and Hematology, Rotterdam, Netherlands

Judith M. Boer

Princess Máxima Center for pediatric oncology, Utrecht, Netherlands; Oncode Institute, Utrecht, Netherlands